Cited by 183Fatty Acid Research and HealthNutritional Studies and DietAquaculture Nutrition and Growth

The Omega-3 Index and relative risk for coronary heart disease mortality: estimation from 10 cohort studies

Harris, William S., Del Gobbo, Liana, Tintle, Nathan L.·2017·Atherosclerosis

Abstract

Background and aims A recent 19-cohort meta-analysis examined the relationships between biomarkers of omega-3 fatty acids and risk for coronary heart disease (CHD). That study did not, however, report hazard ratios (HRs) specifically as a function of erythrocyte eicosapentaenoic (EPA) plus docosahexaenoic (DHA) levels, a metric called the Omega-3 Index in which EPA + DHA content is expressed as a percent of total fatty acids. The Omega-3 Index has been used in several recent studies and is a validated biomarker of omega-3 fatty acid tissue levels, but additional data are needed to confirm (or refute) the originally-proposed clinical cut-points of Methods The present study was therefore undertaken using published data from this meta-analysis to estimate HRs per 1-SD increase in the Omega-3 Index and median quintile values for this metric across 10 of the cohorts for which the needed data were available. Results The overall mean (SD) for the Omega-3 Index in these 10 cohort studies was 6.1% (2.1%), and the HR for a 1-SD increase was 0.85 (95% confidence interval, 0.80-0.91). Median quintile 1 and 5 levels were 4.2% vs. 8.3%, respectively. Based on these values, we estimate that risk for fatal CHD would have been reduced by about 30% moving from an Omega-3 Index of 4%-8%. Conclusions These findings support the use of 8% as reasonable therapeutic targets for the Omega-3 Index.

Integrity signals

Registry

Crossref · 10.1016/j.atherosclerosis.2017.05.007

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Observational studies consistently show that an O3I of ≥8% is ideal for reducing risk of major adverse cardiovascular events, stroke, and all-cause mortality.

    “Observational studies consistently show that an O3I of ≥8% is ideal for reducing risk of major adverse cardiovascular events116 (MACE), stroke20 and all-cause mortality117.”
  • Higher levels of omega-3 biomarkers are associated with lower risk for ASCVD, Alzheimer's disease, total dementia, heart failure, diabetes, suicidal ideation/self-harm, poor lung function, colorectal cancer, several other malignancies, atopic dermatitis, hospitalization for sepsis, liver cirrhosis, chronic kidney disease, frailty, and hip fractures.

    “Other biomarker-based studies have found higher levels of omega-3s to be associated with lower risk for ASCVD116, Alzheimer’s disease130 and total dementia130, heart failure131, diabetes132, suicidal ideation/self-harm133, poor lung function134, colorectal cancer135 and several other malignancies136, atopic dermatitis137, hospitalization for sepsis138, liver cirrhosis139, chronic kidney disease140”

Cites

Flagged first, then by citations

1 of the 52 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Harris, W. S., Del Gobbo, L., & Tintle, N. L.
Affiliations
  • University of South Dakota (US)
  • Dordt University (US)
Corresponding author
Harris, William S.
Venue
Atherosclerosis
Publisher
Elsevier BV
Published
2017-07
Volume
262
Pages
51-54
ISSN
0021-9150 (ISSN-L)
OpenAlex
W2611630545
Cited by
183
References
52
Citations by year
2026: 16 · 2025: 11 · 2024: 19 · 2023: 16 · 2022: 21 · 2021: 21 · 2020: 21 · 2019: 31 · 2018: 23 · 2017: 3 · 2014: 1
FWCI
2.20
Type
journal article
Language
en
Open access
closed
Locations
  • Atherosclerosis (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Nutritional Studies and Diet
  • Life Sciences › Agricultural and Biological Sciences › Aquatic Science › Aquaculture Nutrition and Growth
Keywords
omega-3 index, coronary heart disease mortality, eicosapentaenoic acid, docosahexaenoic acid, omega-3 fatty acids, hazard ratio, therapeutic target, biomarkers
MeSH terms
Diet, Healthy, Coronary Disease, Docosahexaenoic Acids, Erythrocytes, Humans, Prognosis, Risk Factors, Time Factors, Eicosapentaenoic Acid, Cohort Studies, Biomarkers, Risk Assessment, Protective Factors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review